Novo Nordisk A/S: Rybelsus (oral semaglutide 14 mg) demonstrates superior reduction in cardiovascular events in the SOUL trial at ACC 2025
Rybelsus® reduced major adverse cardiovascular events by 14% vs placebo in adults…
Novartis receives third FDA approval for oral Fabhalta (iptacopan) the first and only treatment approved in C3 glomerulopathy (C3G)
Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first…
A Happy Mouth Is a Happy Mind: FDI World Dental Federation features new song to raise awareness of the link between oral health and mental well-being.
GENEVA, March 20, 2025 /PRNewswire/ -- How does oral health affect mental…
TAHO Pharmaceuticals Reports Positive Results from Pivotal Study of TAH3311, the First Oral Dissolving Film Anticoagulant
TAIPEI, Feb. 17, 2025 /PRNewswire/ -- TAHO Pharmaceuticals announces positive preliminary results…
Recursion Presents Phase 2 Data for REC-994 in CCM in Late-Breaking Oral Presentation at the International Stroke Conference
Met primary endpoint of safety and tolerability in CCM patients with no…
NADP Foundation Announces 2025 Grants to Advance Access to Oral Healthcare
January 23, 2025 17:15 ET | Source: National Association of Dental Plans…
COLGATE INTRODUCES A SENSORY EXPERIENCE IN ORAL CARE WITH THE LAUNCH OF A NEW MAXFRESH RANGE
MUMBAI, India, Dec. 23, 2024 /PRNewswire/ -- Colgate-Palmolive (India) Limited, the market…
COLGATE INTRODUCES A SENSORY EXPERIENCE IN ORAL CARE WITH THE LAUNCH OF A NEW MAXFRESH RANGE
MUMBAI, India, Dec. 23, 2024 /PRNewswire/ -- Colgate-Palmolive (India) Limited, the market…
COLGATE INTRODUCES A SENSORY EXPERIENCE IN ORAL CARE WITH THE LAUNCH OF A NEW MAXFRESH RANGE
MUMBAI, India, Dec. 23, 2024 /PRNewswire/ -- Colgate-Palmolive (India) Limited, the market…
COLGATE INTRODUCES A SENSORY EXPERIENCE IN ORAL CARE WITH THE LAUNCH OF A NEW MAXFRESH RANGE
MUMBAI, India, Dec. 23, 2024 /PRNewswire/ -- Colgate-Palmolive (India) Limited, the market…